Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Yoshida

Showing results (311-320 of 316) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 316 results.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 16, 2025
The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long-Term Administration of Nucleos(t)ide AnalogsKazuhiro Murai, Hayato Hikita, Ryoko Yamada, et al.
Journal of Dermatological Science|November 24, 2016
A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoidMasayuki Amagai, Shigaku Ikeda, Takashi Hashimoto, et al.
Journal of Gastroenterology and Hepatology|August 19, 2023
Identification of clinical phenotypes associated with poor prognosis in patients with nonalcoholic fatty liver disease via unsupervised machine learningTakanori Ito, Hikaru Morooka, Hirokazu Takahashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 25, 2024
Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver diseaseKazuhiro Nouso, Miwa Kawanaka, Hideki Fujii, et al.
Nutrients|July 11, 2023
Association of Serum Albumin Levels and Long-Term Prognosis in Patients with Biopsy-Confirmed Nonalcoholic Fatty Liver DiseaseHirokazu Takahashi, Miwa Kawanaka, Hideki Fujii, et al.
Diagnostics (Basel, Switzerland)|July 12, 2025
Tips for Hepatologist Referral of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease with Alanine Aminotransferase Levels ≤ 30 U/LMiwa Kawanaka, Hideki Fujii, Michihiro Iwaki, et al.
Pageof 32

Showing results (311-320 of 316) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 316 results.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 16, 2025
The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long-Term Administration of Nucleos(t)ide AnalogsKazuhiro Murai, Hayato Hikita, Ryoko Yamada, et al.
Journal of Dermatological Science|November 24, 2016
A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoidMasayuki Amagai, Shigaku Ikeda, Takashi Hashimoto, et al.
Journal of Gastroenterology and Hepatology|August 19, 2023
Identification of clinical phenotypes associated with poor prognosis in patients with nonalcoholic fatty liver disease via unsupervised machine learningTakanori Ito, Hikaru Morooka, Hirokazu Takahashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 25, 2024
Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver diseaseKazuhiro Nouso, Miwa Kawanaka, Hideki Fujii, et al.
Nutrients|July 11, 2023
Association of Serum Albumin Levels and Long-Term Prognosis in Patients with Biopsy-Confirmed Nonalcoholic Fatty Liver DiseaseHirokazu Takahashi, Miwa Kawanaka, Hideki Fujii, et al.
Diagnostics (Basel, Switzerland)|July 12, 2025
Tips for Hepatologist Referral of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease with Alanine Aminotransferase Levels ≤ 30 U/LMiwa Kawanaka, Hideki Fujii, Michihiro Iwaki, et al.
Pageof 32